// Workers AI · dad joke modeWhat did Linvemastat say to its friend? "Stat" tuned.

Linvemastat
Clinical data
Other names	FP-020
Identifiers
	IUPAC name 5-[3-[4-[(2-methyl-4-pyridinyl)methoxy]phenyl]sulfanylfuran-2-yl]imidazolidine-2,4-dione;
CAS Number	2389060-50-6;
PubChem CID	146262473;
ChemSpider	129564913;
ChEMBL	ChEMBL5976402;
Chemical and physical data
Formula	C20H17N3O4S
Molar mass	395.43 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=NC=CC(=C1)COC2=CC=C(C=C2)SC3=C(OC=C3)C4C(=O)NC(=O)N4;
	InChI InChI=InChI=1S/C20H17N3O4S/c1-12-10-13(6-8-21-12)11-27-14-2-4-15(5-3-14)28-16-7-9-26-18(16)17-19(24)23-20(25)22-17/h2-10,17H,11H2,1H3,(H2,22,23,24,25); Key:GUKPADSDFUIAMC-UHFFFAOYSA-N;

Linvemastat is an investigational new drug that is being evaluated by Foresee Pharmaceuticals for the treatment of Asthma.^[1] It is a matrix metalloproteinase 12 inhibitor.^[1]^[2]

References

1 2 "Linvemastat". AdisInsight. Springer Nature Switzerland AG. Retrieved 5 July 2026.
↑ Dorjay Tamang JS, Banerjee S, Baidya SK, Das S, Ghosh B, Jha T, et al. (February 2025). "An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies". European Journal of Medicinal Chemistry. 283 117154. doi:10.1016/j.ejmech.2024.117154. PMID 39709794.

This pharmacology-related article is a stub. You can help Wikipedia by adding missing information.